Remote Buying of ALPS Fund Services - ALPS Medical Breakthroughs ETF through IEX is under development on ETFS.com.
Notify Me when it is readyRemote Selling of ALPS Fund Services - ALPS Medical Breakthroughs ETF through IEX is under development on ETFS.com.
Notify Me when it is ready- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Global Medical REIT: Market Dislocation From First To Worst, Opportunity Refreshed via Seeking Alpha
Annex Advisory Services LLC Raises Position in NVIDIA Co. (NASDAQ:NVDA) via ETF Daily News
Pfizer Inc. (NYSE:PFE) Shares Bought by Annex Advisory Services LLC via ETF Daily News
DuPont de Nemours, Inc. (NYSE:DD) Shares Purchased by Wealth Enhancement Advisory Services LLC via ETF Daily News
Texas Instruments Incorporated (NASDAQ:TXN) Shares Acquired by Wealth Enhancement Advisory Services LLC via ETF Daily News
The Home Depot, Inc. (NYSE:HD) Shares Purchased by Annex Advisory Services LLC via ETF Daily News
Annex Advisory Services LLC Raises Holdings in The Walt Disney Company (NYSE:DIS) via ETF Daily News
Annex Advisory Services LLC Has $2.96 Million Stake in Verizon Communications Inc. (NYSE:VZ) via ETF Daily News
Annex Advisory Services LLC Grows Stock Holdings in The Procter & Gamble Company (NYSE:PG) via ETF Daily News
Wealth Enhancement Advisory Services LLC Raises Holdings in Keysight Technologies, Inc. (NYSE:KEYS) via ETF Daily News
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
- Waiting for IEX trades to start ...